Home LiteratureArticle Details
PMID: 21875954 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity.

The Journal of experimental medicine ·Vol. 208 ·No. 10 ·2011-09-26 ·Pages 2033-42

Becker-Herman S, Meyer-Bahlburg A, Schwartz MA, Jackson SW, Hudkins KL, Liu C, Sather BD, Khim S, Liggitt D, Song W, Silverman GJ, Alpers CE, Rawlings DJ

Abstract

Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in B cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro, thereby promoting a B cell-intrinsic break in tolerance. Whereas this defect leads to autoantibody production in WAS protein-deficient (WASp(-/-)) mice without overt disease, chimeric mice in which only the B cell lineage lacks WASp exhibit severe autoimmunity characterized by spontaneous germinal center formation, class-switched autoantibodies, renal histopathology, and early mortality. Both T cell help and B cell-intrinsic TLR engagement play important roles in promoting disease in this model, as depletion with anti-CD4 antibodies or generation of chimeric mice with B cells deficient in both WASp and MyD88 prevented development of autoimmune disease. These data highlight the potentially harmful role for cell-intrinsic loss of B cell tolerance in the setting of normal T cell function, and may explain why WAS patients with mixed chimerism after stem cell transplantation often develop severe humoral autoimmunity.

MeSH Terms
Animals Antibodies, Antinuclear/immunology Autoantibodies/immunology Autoimmunity/immunology B-Lymphocytes/immunology,physiology CD4-Positive T-Lymphocytes/immunology Chimera Female Humans Mice Mice, Inbred C57BL Mice, Knockout Myeloid Differentiation Factor 88/immunology Receptors, Antigen, B-Cell/immunology Toll-Like Receptors/immunology Wiskott-Aldrich Syndrome Protein/deficiency,genetics
Chemicals
Antibodies, Antinuclear Autoantibodies Myd88 protein, mouse Myeloid Differentiation Factor 88 Receptors, Antigen, B-Cell Toll-Like Receptors Wiskott-Aldrich Syndrome Protein
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Becker-Herman Shirly
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA; Seattle Children’s Research Institute, Seattle, WA, USA.
Meyer-Bahlburg Almut
Schwartz Marc A
Jackson Shaun W
Hudkins Kelly L
Liu Chaohong
Sather Blythe D
Khim Socheath
Liggitt Denny
Song Wenxia
Silverman Gregg J
Alpers Charles E
Rawlings David J
References (35)
35 references, click to expand
  1. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    J Pediatr. 1994 Dec;125(6 Pt 1):876-85 PMID: 7996359
  2. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.
    Annu Rev Immunol. 2007;25:419-41 PMID: 17378763
  3. WASp in immune-system organization and function.
    Nat Rev Immunol. 2002 Sep;2(9):635-46 PMID: 12209132
  4. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation.
    Immunity. 2002 Feb;16(2):193-204 PMID: 11869681
  5. Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.
    J Immunol. 2009 Mar 1;182(5):2868-78 PMID: 19234182
  6. Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.
    J Exp Med. 2010 Nov 22;207(12):2767-78 PMID: 21078890
  7. Activating systemic autoimmunity: B's, T's, and tolls.
    Curr Opin Immunol. 2009 Dec;21(6):626-33 PMID: 19800208
  8. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.
    Blood. 2010 Aug 5;116(5):740-7 PMID: 20457871
  9. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.
    Immunity. 2000 Aug;13(2):277-85 PMID: 10981970
  10. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    J Exp Med. 2007 Feb 19;204(2):381-91 PMID: 17296786
  11. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
    J Pathol. 2007 Jan;211(1):67-75 PMID: 17086554
  12. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
    J Clin Invest. 2007 Feb;117(2):407-18 PMID: 17218989
  13. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
    Blood. 2008 Jan 1;111(1):439-45 PMID: 17901250
  14. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.
    Pediatrics. 2003 May;111(5 Pt 1):e622-7 PMID: 12728121
  15. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients.
    Clin Exp Immunol. 2008 Jul;153(1):102-16 PMID: 18510544
  16. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Immunity. 1998 Apr;8(4):497-508 PMID: 9586639
  17. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
    Immunity. 2008 Aug 15;29(2):249-60 PMID: 18691914
  18. Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells.
    J Immunol. 2009 Jan 1;182(1):329-39 PMID: 19109164
  19. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells.
    J Exp Med. 2007 Feb 19;204(2):369-80 PMID: 17296785
  20. Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells.
    Blood. 2007 Dec 15;110(13):4278-84 PMID: 17673604
  21. Recent advances in the biology of WASP and WIP.
    Immunol Res. 2009;44(1-3):99-111 PMID: 19018480
  22. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis.
    Blood. 2008 Nov 15;112(10):4158-69 PMID: 18687984
  23. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88.
    Nat Immunol. 2010 Sep;11(9):836-45 PMID: 20676093
  24. B cell selection and susceptibility to autoimmunity.
    J Immunol. 2005 Feb 15;174(4):1775-81 PMID: 15699102
  25. Spontaneous formation of germinal centers in autoimmune mice.
    J Leukoc Biol. 2001 Oct;70(4):578-84 PMID: 11590194
  26. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.
    Am J Pathol. 2001 Dec;159(6):2355-69 PMID: 11733384
  27. Divergent immunoglobulin g subclass activity through selective Fc receptor binding.
    Science. 2005 Dec 2;310(5753):1510-2 PMID: 16322460
  28. Activation of autoreactive B cells by CpG dsDNA.
    Immunity. 2003 Dec;19(6):837-47 PMID: 14670301
  29. B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c.
    J Immunol. 2009 Jul 15;183(2):1005-12 PMID: 19542370
  30. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
    J Exp Med. 2006 Mar 20;203(3):553-61 PMID: 16492804
  31. BAFF and MyD88 signals promote a lupuslike disease independent of T cells.
    J Exp Med. 2007 Aug 6;204(8):1959-71 PMID: 17664289
  32. Clinical course of patients with WASP gene mutations.
    Blood. 2004 Jan 15;103(2):456-64 PMID: 12969986
  33. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation.
    J Exp Med. 2008 Jan 21;205(1):155-68 PMID: 18180309
  34. Exogenous and endogenous TLR ligands activate anti-chromatin and polyreactive B cells.
    J Immunol. 2006 Jun 1;176(11):6491-502 PMID: 16709806
  35. Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.
    Immunobiology. 2009;214(9-10):778-90 PMID: 19628299
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
1540-9538
Published
2011-09-26
Epub
2011-00-29
Pages
2033-42
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC3182055
Subset
IM
Grants
NICHD NIH HHS · HD037091 · United States
NIAMS NIH HHS · 5T32AR007108-32 · United States
NICHD NIH HHS · R01 HD037091 · United States
NIDDK NIH HHS · DK76126 · United States
NIAID NIH HHS · R56 AI071163 · United States
NIAMS NIH HHS · T32 AR007108 · United States
NIAID NIH HHS · R01 AI071163 · United States
NIDDK NIH HHS · U24 DK076126 · United States
NIAID NIH HHS · R01 AI040305 · United States
NIAID NIH HHS · AI071163 · United States
NIAID NIH HHS · AI46637 · United States
NIAID NIH HHS · AI40305 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com